Consumer access to effective and affordable medicines is an imperative for public health, social equity, and economic development, but this need is not being served adequately by the biopharmaceutical sector,…
The post Making Medicines Affordable…
Making Medicines Affordable: A National Imperative Read Post »
Contrary to popular belief, there are many unapproved drugs which are actively being used. Many physicians may not even realize that that the drugs they are prescribing have not been…
The post Unapproved Drugs: Opportunities for Rapid Approval an…
Unapproved Drugs: Opportunities for Rapid Approval and Market Exclusivity Read Post »
Changes in the pharmaceutical sales model have forced leaders to invest in new selling strategies in recent years. However most of these New Commercial Models (NCMs) have not produced enough…
The post Strategies for Pharmaceutical Companies to Bo…
Strategies for Pharmaceutical Companies to Boost Their Exports Read Post »
This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied Sci. 2010 Jan-Mar; 2(1): 2–7. Abstract It is widely recognized…
The post Patent Protection Strategies appeared first on Dr…
Annual Drug Patent Expirations for OXANDRIN Oxandrin is a drug marketed by Gemini Labs Llc and is included in one NDA. There are four patents protecting this drug and one…
The post New patent expiration for Gemini Labs drug OXANDRIN appeared firs…
New patent expiration for Gemini Labs drug OXANDRIN Read Post »
Annual Drug Patent Expirations for RYBIX+ODT Rybix Odt is a drug marketed by Shionogi Inc and is included in one NDA. There is one patent protecting this drug. This drug…
The post New patent expiration for Shionogi Inc drug RYBIX ODT appeared fir…
New patent expiration for Shionogi Inc drug RYBIX ODT Read Post »
Annual Drug Patent Expirations for FAZACLO+ODT Fazaclo Odt is a drug marketed by Jazz Pharms Iii and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Jazz Pharms drug FAZACLO ODT appeared f…
New patent expiration for Jazz Pharms drug FAZACLO ODT Read Post »
We must achieve a balance between the current and future needs of patients and the timely introduction of existing and new pharmaceutical drugs Dr. Ashish Bharadwaj is a faculty member at…
The post Balancing Patents and Drug Prices appeared first…
A 2016 report by the Kaiser Family Foundation reported that approximately one-quarter of the people in the United States have difficulty affording their medications. For low-income individuals, the cost of…
The post Re-Thinking Management Strateg…
Re-Thinking Management Strategies for Specialty Drug Cost Containment Read Post »
This article was originally published by Kiran Mazumdar Shaw in IIMB Management Review under a Creative Commons license. Abstract Affordable innovation, which presents ways to innovate, be flexible, and do more with…
The post Leveraging affordabl…
Leveraging affordable innovation to tackle India’s healthcare challenge Read Post »